The Uromigos Episode 319: ASCO 2024 GU Preview | GU Oncology Now
Silke Gillessen joins Brian and Tom to give a preview of this year’s ASCO annual meeting, including presentations to look out for on the prostate, bladder, and kidney cancer.
Silke Gillessen joins Brian and Tom to give a preview of this year’s ASCO annual meeting, including presentations to look out for on the prostate, bladder, and kidney cancer.
This cohort study investigates the association between measured physical activity and Eastern Cooperative Oncology Group Performance Status, as well as the potential prognostic value of…
Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease (MRD), disease recurrence, and benefit from adjuvant atezolizumab (Tecentriq) in patients with…
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Treatment with FDA-approved CAR T-cell therapies for non-Hodgkin lymphoma was efficacious and feasible in patients with Richter transformation.
Datopotamab deruxtecan demonstrated comparable intracranial activity and safety in pretreated patients with NSCLC with or without brain metastases.
Can metformin use be linked to a lower risk of myeloproliferative neoplasms? Find out from this groundbreaking study.
The treatment of childhood acute lymphoblastic leukemia (ALL) has reached overall survival rates exceeding 90%. The present and future challenges are to cure the remainder…
The 29th Congress of the European Hematology Association (EHA) will be held in Madrid, Spain, and online, from June 13-16, 2024. This meeting will bring…
Michael Parry was diagnosed with pancreatic cancer at the age of 59. Fortunately, his disease was detected early โ and after surgery and chemotherapy, he…
The 29th Congress of the European Hematology Association (EHA) will be held in Madrid, Spain, and online, from June 13-16, 2024. This meeting will bring…